Clinical Trial Update: Predictor of Advanced Sub-Clinical Atherosclerosis (PASA) Study [NA]

View source ↗

Summary

The PASA study evaluating predictors of advanced sub-clinical atherosclerosis conducted by the University of Wisconsin–Madison has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis

Snippet

Sponsor: University of Wisconsin, Madison | Conditions: Atherosclerosis | NA | Status: COMPLETED